Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

BUY
$27.86 - $35.93 $4.97 Million - $6.42 Million
178,571 Added 6.89%
2,768,586 $80 Million
Q4 2019

Feb 13, 2020

BUY
$13.55 - $26.15 $35.1 Million - $67.7 Million
2,590,015 New
2,590,015 $63.3 Million

Others Institutions Holding OYST

About Oyster Point Pharma, Inc.


  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Invus Financial Advisors, LLC Portfolio

Follow Invus Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invus Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invus Financial Advisors, LLC with notifications on news.